Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

332
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
332
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

767
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
767
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

2.0K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K
Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
Conserved Binding Sites01:49

Conserved Binding Sites

5.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-partitioning strategy, plastid and nuclear phylogenomic discordance, and its evolutionary implications of <i>Clematis</i> (Ranunculaceae).

Frontiers in plant science·2022
Same author

Quantification and visualization of meat quality traits in pork using hyperspectral imaging.

Meat science·2022
Same author

Super-Assembled Multi-Level Asymmetric Mesochannels for Coupled Accelerated Dual-Ion Selective Transport.

Advanced materials (Deerfield Beach, Fla.)·2022
Same author

International Alliance of Urolithiasis Guideline on Shockwave Lithotripsy.

European urology focus·2022
Same author

Controlled propulsion of micro/nanomotors: operational mechanisms, motion manipulation and potential biomedical applications.

Chemical Society reviews·2022
Same author

Temperature-Regulated Core Swelling and Asymmetric Shrinkage for Tunable Yolk@Shell Polydopamine@Mesoporous Silica Nanostructures.

Small (Weinheim an der Bergstrasse, Germany)·2022

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.7K

Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics.

See Hong Chiu1, Lei Xie1,2

  • 1Department of Computer Science, The Graduate Center, The City University of New York , 365 Fifth Avenue, New York, New York 10016, United States.

Journal of Chemical Information and Modeling
|May 10, 2016
PubMed
Summary

Drug potency in vitro doesn't predict in vivo activity. This study integrates normal mode analysis with machine learning to accurately predict protein-ligand binding kinetics, enabling high-throughput drug screening based on kinetic properties.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Biophysics

Background:

  • In vitro drug potency often fails to predict in vivo activity.
  • Protein-ligand interaction kinetics, not just thermodynamics, are crucial for in vivo efficacy.
  • Current methods lack the scale and detail to study binding/unbinding kinetics effectively.

Purpose of the Study:

  • To develop a computational method for large-scale analysis of protein-ligand interaction kinetics.
  • To enable high-throughput screening and optimization of drug leads based on kinetic properties.
  • To bridge the gap between in vitro screening and in vivo drug activity.

Main Methods:

  • Integration of coarse-grained normal mode analysis with multitarget machine learning (MTML).
  • Utilizing residue normal mode directionality displacement as a kinetic fingerprint.
  • Testing the method on the HIV-1 protease system.

Main Results:

  • The integrated computational model accurately predicts protein-ligand binding/unbinding kinetics.
  • Prediction accuracy for association (kon) and dissociation (koff) rates reached 74.35% when combined with energetic features.
  • The method recapitulates results from all-atom molecular dynamics simulations.

Conclusions:

  • Residue normal mode directionality displacement effectively captures long-time-scale conformational dynamics relevant to binding kinetics.
  • The integrated approach provides mechanistic insights into kinetic determinants of protein-ligand interactions.
  • This computational strategy offers a practical platform for high-throughput kinetic screening in drug discovery.